Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Haussecker

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The FEBS Journal|April 20, 2016
Stacking up CRISPR against RNAi for therapeutic gene inhibitionDirk Haussecker
Human Gene Therapy|April 26, 2008
The business of RNAi therapeuticsDirk Haussecker
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2018
RNAi Arrives at the Bedside after a Mere Two DecadesDirk Haussecker
Molecular Therapy. Nucleic Acids|January 25, 2013
The Business of RNAi Therapeutics in 2012Dirk Haussecker
Molecular and Cellular Biology|October 18, 2005
Dicer-dependent turnover of intergenic transcripts from the human beta-globin gene clusterDirk Haussecker, Nicholas J Proudfoot
Science (New York, N.Y.)|March 7, 2015
RNA interference. Drugging RNAiDirk Haussecker, Mark A Kay
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2010
miR-122 continues to blaze the trail for microRNA therapeuticsDirk Haussecker, Mark A Kay
RNA (New York, N.Y.)|September 25, 2009
Combined proteomic-RNAi screen for host factors involved in human hepatitis delta virus replicationDan Cao, Dirk Haussecker, Yong Huang, et al.
RNA (New York, N.Y.)|February 26, 2010
Human tRNA-derived small RNAs in the global regulation of RNA silencingDirk Haussecker, Yong Huang, Ashley Lau, et al.
Nature Structural & Molecular Biology|June 17, 2008
Capped small RNAs and MOV10 in human hepatitis delta virus replicationDirk Haussecker, Dan Cao, Yong Huang, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The FEBS Journal|April 20, 2016
Stacking up CRISPR against RNAi for therapeutic gene inhibitionDirk Haussecker
Human Gene Therapy|April 26, 2008
The business of RNAi therapeuticsDirk Haussecker
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2018
RNAi Arrives at the Bedside after a Mere Two DecadesDirk Haussecker
Molecular Therapy. Nucleic Acids|January 25, 2013
The Business of RNAi Therapeutics in 2012Dirk Haussecker
Molecular and Cellular Biology|October 18, 2005
Dicer-dependent turnover of intergenic transcripts from the human beta-globin gene clusterDirk Haussecker, Nicholas J Proudfoot
Science (New York, N.Y.)|March 7, 2015
RNA interference. Drugging RNAiDirk Haussecker, Mark A Kay
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2010
miR-122 continues to blaze the trail for microRNA therapeuticsDirk Haussecker, Mark A Kay
RNA (New York, N.Y.)|September 25, 2009
Combined proteomic-RNAi screen for host factors involved in human hepatitis delta virus replicationDan Cao, Dirk Haussecker, Yong Huang, et al.
RNA (New York, N.Y.)|February 26, 2010
Human tRNA-derived small RNAs in the global regulation of RNA silencingDirk Haussecker, Yong Huang, Ashley Lau, et al.
Nature Structural & Molecular Biology|June 17, 2008
Capped small RNAs and MOV10 in human hepatitis delta virus replicationDirk Haussecker, Dan Cao, Yong Huang, et al.
Pageof 2